WASHINGTON (AP) — Democratic leaders in Congress say a nonpartisan analysis showing a Republican health insurance bill would leave 24 million more people uninsured over the next decade should be a "knockout blow." The White House says it disagrees strenuously with the assessment of the nonpartisan Congressional Budget Office. House Democratic Leader Nancy Pelosi says Speaker Paul Ryan should pull the bill from consideration, saying, "It's really the only decent thing to do."
WASHINGTON (AP) — The Justice Department says it needs more time to respond to lawmakers demands for any proof to back up President Donald Trump's accusation that he was wiretapped by former President Barack Obama. The House Intelligence Committee had expected a response today. It's also investigating Russian interference in the 2016 presidential election. A Justice Department spokeswoman said in a statement that the agency is reviewing the request "to determine what if any responsive documents may exist."
WASHINGTON (AP) — Democrats and some Republicans are criticizing veteran Republican Rep. Steve King for saying America can't restore "our civilization with somebody else's babies." In an interview today on CNN, King said he stood by his remarks. King is known for making racially charged commentary. Last year, at the Republican National Convention, King questioned contributions to civilization by nonwhites.
FERGUSON, Mo. (AP) — A filmmaker is denying that surveillance video in his documentary about the Michael Brown case in Ferguson, Missouri, was edited in a deceptive way. Jason Pollock's documentary raises new questions about events leading up to the fatal Aug. 9, 2014, encounter in which white Ferguson police officer Darren Wilson fatally shot Brown, who was 18, black and unarmed. Wilson was later cleared of wrongdoing. The case sparked racial unrest.
TRENTON, N.J. (AP) — U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer. The drug, called Kisqali (KISSX'-qahl-lee) and developed by Swiss drugmaker Novartis AG, is a pill that works to slow the spread of cancer by blocking two proteins that can stimulate growth and division of cancer cells. It's for women who have a common form of metastatic breast cancer.